Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H10I4NO4.Na |
| Molecular Weight | 798.8518 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O
InChI
InChIKey=YDTFRJLNMPSCFM-YDALLXLXSA-M
InChI=1S/C15H11I4NO4.Na/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23;/h1-2,4-5,12,21H,3,20H2,(H,22,23);/q;+1/p-1/t12-;/m0./s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10840
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID90883228
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
55-03-8
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
200-221-4
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
LEVOTHYROXINE SODIUM ANHYDROUS
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | Description: An almost white or slightly coloured powder, or a fine, slightly coloured, crystalline powder; odourless. Solubility: Very slightly soluble in water; slightly soluble in ethanol (~750 g/L) TS; practically insoluble in acetone R and ether R. It dissolves in solutions of alkali hydroxides. Category: Thyroid hormone.Storage: Levothyroxine sodium should be kept in a tightly closed container, protected from light.Additional information: Levothyroxine sodium may contain a variable quantity of water of crystallization; anhydrous levothyroxine sodium is hygroscopic. Definition: Levothyroxine sodium contains not less than 97.0% and not more than 101.0% of C15H10I4NNaO4, calculated with reference to the dried substance. | ||
|
054I36CPMN
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
C175725
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
453
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
054I36CPMN
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
SUB122637
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
ALTERNATIVE | |||
|
23666112
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
6446
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
259940
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
SUB08495MIG
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | |||
|
1372638
Created by
admin on Fri Dec 15 15:50:00 UTC 2023 , Edited by admin on Fri Dec 15 15:50:00 UTC 2023
|
PRIMARY | RxNorm |
ACTIVE MOIETY
SUBSTANCE RECORD